UK diagnostics group Owlstone Medical and Cancer Research UK have kicked off a study aiming to identify breath biomarkers to improve the early detection and diagnosis of multiple cancer types.
Read More
UK diagnostics group Owlstone Medical has kicked off a 1,400 patient clinical trial assessing the potential of its FAIMS (Field Asymmetric Ion Mobility Spectrometer) technology in the early detection of colorectal cancer, which it claims to be the world’s largest breath-based study into the disease.
Read More
New clinical data presented at the European Cancer Congress has raised hopes of a breath test that can successfully detect cancers of the oesophagus and stomach, side-stepping the need for endoscopy, the traditional method of diagnosis.
Read More
